
SNNVF does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for SNNVF and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SNNVF and 80,000+ other tickers.
See exactly how SNNVF's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SNNVF and 80,000+ other tickers.
Sunniva Inc. is a fully integrated cannabis enterprise that specializes in the comprehensive development of therapeutic cannabis solutions, from cultivation and production to final distribution, primarily serving markets in Canada and the United States. The company organizes its operations into three distinct areas: Patient Counselling, Merchandising, and Cultivation & Extraction. Its product line is marketed under specific brand names, including Sun Fire, Kyndness, and Herbella. Originally founded in 2014 as Sunniva Holdings Corp., the firm officially adopted the name Sunniva Inc. in August 2017. The company's headquarters are situated in Vancouver, Canada.